Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine for uncomplicated falciparum and vivax malaria in Solomon Islands
ACTRN12615000748516Phase 4Completed
- Sponsor
- Ministry of Health
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lumefantrine in malaria, Falciparum malaria (PF) and vivax malaria (2 cohorts), sponsored by Ministry of Health. Primary endpoint: Therapeutic efficacy at day 28. Started Jun 2008; status: completed.
02
Drugs
lumefantrine
03
Conditions
malariaFalciparum malaria (PF)vivax malaria
Beyond the preview
Go deeper on ACTRN12615000748516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000748516.